| Entry |
|
| Name |
Ibopamine hydrochloride;
Scandine (TN)
|
| Formula |
C17H25NO4. HCl
|
| Exact mass |
343.155
|
| Mol weight |
343.8456
|
| Structure |

     |
| Activity |
Cardiac
|
| Remark |
|
| Target |
dopamine D1-receptor agonist [HSA: 1812] [KO: K04144]; dopamine D2-receptor agonist [HSA: 1813] [KO: K04145] |
| Pathway |
|
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA16 Ibopamine
D08057 Ibopamine hydrochloride
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01F MYDRIATICS AND CYCLOPLEGICS
S01FB Sympathomimetics excl. antiglaucoma preparations
S01FB03 Ibopamine
D08057 Ibopamine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
dopamine D1-receptor [HSA:1812] [KO:K04144]
Ibopamine [ATC:C01CA16 S01FB03]
D08057 Ibopamine hydrochloride
dopamine D2-receptor [HSA:1813] [KO:K04145]
Ibopamine [ATC:C01CA16 S01FB03]
D08057 Ibopamine hydrochloride
 |
| Other DBs |
CAS: 75011-65-3 PubChem: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 23
1 C8y C 24.1500 -17.8500
2 C8y C 25.3400 -17.1500
3 C8x C 24.1500 -19.2500
4 O7a O 22.9600 -17.1500
5 C8x C 26.5300 -17.8500
6 O7a O 25.3400 -15.7500
7 C8y C 25.3400 -19.9500
8 C7a C 21.7000 -17.8500
9 C8x C 26.5300 -19.2500
10 C7a C 26.5300 -15.1200
11 C1b C 25.3400 -21.3500
12 C1c C 20.5100 -17.1500
13 O6a O 21.7000 -19.2500
14 C1c C 27.7900 -15.8200
15 O6a O 26.5300 -13.7200
16 C1b C 26.5300 -22.0500
17 N1b N 27.7900 -21.3500
18 C1a C 29.0500 -22.1200
19 C1a C 19.3200 -17.8500
20 C1a C 20.5100 -15.7500
21 C1a C 28.9800 -15.1200
22 C1a C 27.7900 -17.2200
23 X Cl 33.0400 -18.9000
BOND 22
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 4 8 1
8 5 9 1
9 6 10 1
10 7 11 1
11 8 12 1
12 8 13 2
13 10 14 1
14 10 15 2
15 11 16 1
16 16 17 1
17 17 18 1
18 7 9 2
19 12 19 1
20 12 20 1
21 14 21 1
22 14 22 1
|